Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID)

Clinical trial NCT02847260 · COMPLETED

Trial details

NCT number: NCT02847260
Sponsor: United Therapeutics
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2012-04-01
Primary completion: 2014-03-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.